Health leaders hope full FDA approval will sway people hesitant to get COVID-19 vaccine
Three vaccines have emergency use authorization, Pfizer and BioNTech are first to submit request for full approval
Impact of full FDA approval on vaccine hesitancy By Morgan Hightower | May 19, 2021 at 3:07 PM CDT - Updated May 19 at 5:19 PM
BIRMINGHAM, Ala. (WBRC) – Vaccination rates are steadily declining in Alabama and it’s not because everyone is vaccinated. Daily doses peaked in April at more than 44,000, according to data from the Alabama Department of Public Health (ADPH). For the week of May 11, daily doses averaged around 15,000.
ADPH conducted a survey in March to better understand reasons for hesitancy. It found, “The primary driver of vaccine resistance among all groups is the speed with which the vaccine was developed. People are worried about long-term side effects they perceive to have not been studied or identified. Lack of trust in the government also appeared as
Emory participating in Moderna COVID-19 variant vaccine study emory.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from emory.edu Daily Mail and Mail on Sunday newspapers.
FDA considering third vaccine that could speed up Alabamians getting vaccinated
FDA to consider third vaccine By Kailey Schuyler | February 26, 2021 at 7:23 AM CST - Updated February 26 at 7:23 AM
HUNTSVILLE, Ala. (WAFF) -The U.S. could soon have three vaccines at its disposal. An FDA panel is set to review the Johnson and Johnson vaccine today.
This vaccine could be a real game-changer. The reason it is being viewed with such hope is that it only requires one dose.
At last check, 583,000 Alabamians had received one dose of Pfizer or Moderna, but only 250,000 completed both doses.
Dr. Paul Goepfert director of UAB’s Alabama Vaccine Research Clinic, says that there are supposed to be 20 million doses available by the end of March.